These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33626627)

  • 1. [Review of near real-time vaccine safety surveillance].
    Sun YX; Liu ZK; Nie XL; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Feb; 42(2):351-356. PubMed ID: 33626627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Develop the active surveillance system for vaccine safety in China].
    Cai T; Zhan SY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):664-667. PubMed ID: 31288335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participant-centred active surveillance of adverse events following immunisation: a narrative review.
    Cashman P; Macartney K; Khandaker G; King C; Gold M; Durrheim DN
    Int Health; 2017 May; 9(3):164-176. PubMed ID: 28582563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Scoping review of active surveillance systems for vaccine safety world-wide].
    Cai T; Liu LL; Yao XY; Liu ZK; Yang Y; Meng RR; Zhan SY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):724-730. PubMed ID: 31288345
    [No Abstract]   [Full Text] [Related]  

  • 5. Routine surveillance of adverse events following immunization as an important tool to monitor vaccine safety.
    Alicino C; Merlano C; Zappettini S; Schiaffino S; Della Luna G; Accardo C; Gasparini R; Durando P; Icardi G
    Hum Vaccin Immunother; 2015; 11(1):91-4. PubMed ID: 25483520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of reporting rates of adverse events following immunization: an international comparison of post-marketing surveillance programs with reference to China.
    Guo B; Page A; Wang H; Taylor R; McIntyre P
    Vaccine; 2013 Jan; 31(4):603-17. PubMed ID: 23200940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance for adverse events following immunization (AEFI) for 7 years using a computerised vaccination system.
    Alguacil-Ramos AM; Muelas-Tirado J; Garrigues-Pelufo TM; Portero-Alonso A; Diez-Domingo J; Pastor-Villalba E; Lluch-Rodrigo JA
    Public Health; 2016 Jun; 135():66-74. PubMed ID: 26976484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of adverse events following the introduction of 13-valent pneumococcal conjugate vaccine in infants, and comparison with adverse events following 7-valent pneumococcal conjugate vaccine, in Victoria, Australia.
    Littlejohn ES; Clothier HJ; Perrett KP; Danchin M
    Hum Vaccin Immunother; 2015; 11(7):1828-35. PubMed ID: 26075435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-marketing safety surveillance for inactivated and live-attenuated Japanese encephalitis vaccines in China, 2008-2013.
    Wu W; Liu D; Li K; Nuorti JP; Nohynek HM; Xu D; Ye J; Zheng J; Wang H
    Vaccine; 2017 Jun; 35(29):3666-3671. PubMed ID: 28552510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015.
    Wu W; Liu D; Nuorti JP; Li K; Xu D; Ye J; Zheng J; Cao L; Wang H
    Vaccine; 2019 Feb; 37(9):1182-1187. PubMed ID: 30709723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events following immunization in Ontario's female school-based HPV program.
    Harris T; Williams DM; Fediurek J; Scott T; Deeks SL
    Vaccine; 2014 Feb; 32(9):1061-6. PubMed ID: 24440208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active SMS-based influenza vaccine safety surveillance in Australian children.
    Pillsbury A; Quinn H; Cashman P; Leeb A; Macartney K;
    Vaccine; 2017 Dec; 35(51):7101-7106. PubMed ID: 29128379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active surveillance for adverse events following immunization.
    Crawford NW; Clothier H; Hodgson K; Selvaraj G; Easton ML; Buttery JP
    Expert Rev Vaccines; 2014 Feb; 13(2):265-76. PubMed ID: 24350637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of pentavalent DTaP-IPV/Hib combination vaccine in post-marketing surveillance in Guangzhou, China, from 2011 to 2017.
    Li Z; Xu J; Tan H; Zhang C; Chen J; Ni L; Yun X; Huang Y; Wang W
    Int J Infect Dis; 2020 Oct; 99():149-155. PubMed ID: 32795602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous active surveillance of adverse events following immunisation using SMS technology.
    Westphal DW; Williams SA; Leeb A; Effler PV
    Vaccine; 2016 Jun; 34(29):3350-5. PubMed ID: 27206385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse events following immunization: is this time for the use of WHO causality assessment?
    Tafuri S; Gallone MS; Calabrese G; Germinario C
    Expert Rev Vaccines; 2015 May; 14(5):625-7. PubMed ID: 25805053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing vaccine safety capacity globally: A lifecycle perspective.
    Chen RT; Shimabukuro TT; Martin DB; Zuber PL; Weibel DM; Sturkenboom M
    Vaccine; 2015 Nov; 33 Suppl 4(0 4):D46-54. PubMed ID: 26433922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Operational lessons learned in conducting a multi-country collaboration for vaccine safety signal verification and hypothesis testing: The global vaccine safety multi country collaboration initiative.
    Guillard-Maure C; Elango V; Black S; Perez-Vilar S; Castro JL; Bravo-Alcántara P; Molina-León HF; Weibel D; Sturkenboom M; Zuber PLF;
    Vaccine; 2018 Jan; 36(3):355-362. PubMed ID: 28780118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-licensure rapid immunization safety monitoring program (PRISM) data characterization.
    Baker MA; Nguyen M; Cole DV; Lee GM; Lieu TA
    Vaccine; 2013 Dec; 31 Suppl 10():K98-112. PubMed ID: 24331080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.